Letters Cost of preventive drugs Dare to tell? BMJ 2011; 342 doi: https://doi.org/10.1136/bmj.d3198 (Published 24 May 2011) Cite this as: BMJ 2011;342:d3198 Article Related content Metrics Responses Peer review Related articles Views & Reviews Dare to know: risk illiteracy and shared decision making Published: 06 April 2011; BMJ 342 doi:10.1136/bmj.d2075 See more Chemoprevention of colorectal cancer in individuals with previous colorectal neoplasia: systematic review and network meta-analysis BMJ December 05, 2016, 355 i6188; DOI: https://doi.org/10.1136/bmj.i6188 NHS to fund large trial of pre-exposure prophylaxis for HIV prevention BMJ December 05, 2016, 355 i6537; DOI: https://doi.org/10.1136/bmj.i6537 Bill to boost medical research funding and speed drug approval passes US house BMJ December 01, 2016, 355 i6498; DOI: https://doi.org/10.1136/bmj.i6498 Alpha blockers for treatment of ureteric stones: systematic review and meta-analysis BMJ December 01, 2016, 355 i6112; DOI: https://doi.org/10.1136/bmj.i6112 Sixty seconds on . . . solanezumab BMJ November 29, 2016, 355 i6389; DOI: https://doi.org/10.1136/bmj.i6389
